PDCD1 and neoplasm: Some studies have found that the tumors significantly shrink or do not progress after PD‐1 blocking treatment, accounting for 48% of the total number of studies; after the treatment, the tumor directly increased or shrank first and then increased, accounting for 52% of the total number of patients.2